Work

NCCTG phase II trial of bevacizumab in combination with sorafenib in recurrent GBM.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2018

Authors: E. Galanis, K. A. Jaeckle, S. Anderson, T. J. Kaufmann, J. H. Uhm, C. Giannini, S. Kumar, D. W. Northfelt, P. J. Flynn, J. C. Buckner

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2263367667

Cites:

Cited by: 6

Related to: 10